These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease. Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265 [TBL] [Abstract][Full Text] [Related]
3. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease. Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843 [TBL] [Abstract][Full Text] [Related]
4. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Rosen RF; Ciliax BJ; Wingo TS; Gearing M; Dooyema J; Lah JJ; Ghiso JA; LeVine H; Walker LC Acta Neuropathol; 2010 Feb; 119(2):221-33. PubMed ID: 19690877 [TBL] [Abstract][Full Text] [Related]
9. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome. Zammit MD; Tudorascu DL; Laymon CM; Hartley SL; Zaman SH; Ances BM; Johnson SC; Stone CK; Mathis CA; Klunk WE; Cohen AD; Handen BL; Christian BT Neuroimage; 2021 Mar; 228():117728. PubMed ID: 33421595 [TBL] [Abstract][Full Text] [Related]
10. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan. LeVine H; Spielmann HP; Matveev S; Cauvi FM; Murphy MP; Beckett TL; McCarty K; Lott IT; Doran E; Schmitt F; Head E Neurobiol Aging; 2017 Jun; 54():163-169. PubMed ID: 28385551 [TBL] [Abstract][Full Text] [Related]
11. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Svedberg MM; Hall H; Hellström-Lindahl E; Estrada S; Guan Z; Nordberg A; Långström B Neurochem Int; 2009; 54(5-6):347-57. PubMed ID: 19162107 [TBL] [Abstract][Full Text] [Related]
12. The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease. Boon BDC; Bulk M; Jonker AJ; Morrema THJ; van den Berg E; Popovic M; Walter J; Kumar S; van der Lee SJ; Holstege H; Zhu X; Van Nostrand WE; Natté R; van der Weerd L; Bouwman FH; van de Berg WDJ; Rozemuller AJM; Hoozemans JJM Acta Neuropathol; 2020 Dec; 140(6):811-830. PubMed ID: 32926214 [TBL] [Abstract][Full Text] [Related]
13. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains. Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613 [TBL] [Abstract][Full Text] [Related]
14. Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome. Ichimata S; Martinez-Valbuena I; Lee S; Li J; Karakani AM; Kovacs GG Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511361 [TBL] [Abstract][Full Text] [Related]
15. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ). Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Wisniewski T; Miller DL J Alzheimers Dis; 2018; 62(4):1635-1649. PubMed ID: 29504532 [TBL] [Abstract][Full Text] [Related]